112 related articles for article (PubMed ID: 6734889)
1. Change from inhibition to stimulation by levan of AKR lymphoma following serial transfers.
Leibovici J; Hoenig S; Stark Y; Kopel S; Wolman M
Exp Cell Biol; 1984; 52(4):219-24. PubMed ID: 6734889
[TBL] [Abstract][Full Text] [Related]
2. Different stages of tumor development are unequally affected by pretreatment of tumor cells with a polysaccharide.
Michowitz M; Stark Y; Leibovici J
Cancer Lett; 1984 Jul; 23(3):343-9. PubMed ID: 6744256
[TBL] [Abstract][Full Text] [Related]
3. Serial passage of tumors in mice in the study of tumor progression and testing of antineoplastic drugs.
Leibovici J
Cancer Res; 1984 May; 44(5):1981-4. PubMed ID: 6713396
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous AKR lymphomas differ in their degree of malignancy and sensitivity to the polysaccharide levan.
Leibovici J
Experientia; 1983 Mar; 39(3):326-7. PubMed ID: 6825804
[TBL] [Abstract][Full Text] [Related]
5. Effects of high-molecular levan on the growth and spread of lymphoma in AKR mice.
Leibovici J; Sinai Y; Wolman M; Davidai G
Cancer Res; 1975 Aug; 35(8):1921-5. PubMed ID: 1149016
[TBL] [Abstract][Full Text] [Related]
6. Effect of tumor inhibitory and stimulatory doses of levan, alone and in combination with cyclophosphamide, on spleen and lymph nodes.
Leibovici J; Kopel S; Siegal A; Gal-Mor O
Int J Immunopharmacol; 1986; 8(4):391-403. PubMed ID: 3744640
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory and stimulatory effects of levan on growth of B16 melanoma--possible mechanisms.
Yavetz H; Davidai G; Leibovici J; Wolman M
Cell Mol Biol; 1985; 31(5):343-7. PubMed ID: 4084939
[No Abstract] [Full Text] [Related]
8. Effects of route and schedule of administration of high-molecular levan on the growth of AKR lymphoma.
Sinai Y; Leibovici J; Wolman M
Cancer Res; 1976 May; 36(5):1593-7. PubMed ID: 1268821
[TBL] [Abstract][Full Text] [Related]
9. Different effects of the polysaccharide levan on the oncogenicity of cells of two variants of Lewis lung carcinoma.
Stark Y; Leibovici J
Br J Exp Pathol; 1986 Feb; 67(1):141-7. PubMed ID: 3947532
[TBL] [Abstract][Full Text] [Related]
10. Change in the role of the spleen from protective to harmful following tumor progression in AKR lymphoma.
Leibovici J; Michowitz M; Argaman H
Invasion Metastasis; 1990; 10(5):289-300. PubMed ID: 2228517
[TBL] [Abstract][Full Text] [Related]
11. Effect of cyclophosphamide and levan treatment on bone marrow and peripheral blood cells in B16-F10 melanoma-bearing mice.
Leibovici J; Siegal A; Kopel S; Davidai G; Yavetz H
Int J Immunopharmacol; 1989; 11(2):133-47. PubMed ID: 2703278
[TBL] [Abstract][Full Text] [Related]
12. Direct antitumor effect of high-molecular-weight levan on Lewis lung carcinoma cells in mice.
Leibovici J; Susskind-Brudner G; Wolman M
J Natl Cancer Inst; 1980 Aug; 65(2):391-6. PubMed ID: 6931256
[TBL] [Abstract][Full Text] [Related]
13. Combined effect of levan and cytotoxic agents on the growth of experimental tumours in mice.
Leibovici J; Stark Y; Wolman M
Br J Exp Pathol; 1983 Jun; 64(3):239-44. PubMed ID: 6882675
[TBL] [Abstract][Full Text] [Related]
14. Suppression of humoral immune response in mice by administration of high molecular levan.
Hoenig S; Katzap I; Leibovici J
Experientia; 1978 Oct; 34(10):1362-3. PubMed ID: 738425
[TBL] [Abstract][Full Text] [Related]
15. Effect of levan on tumorigenicity of cells from different murine tumors.
Stark Y; Leibovici J
Cell Mol Biol; 1984; 30(5):425-30. PubMed ID: 6529736
[No Abstract] [Full Text] [Related]
16. Effect of levan on the fate of experimental hematogenous metastases of Lewis lung carcinoma.
Bubis JJ; Leibovici J; Miron E; Michowitz M; Wolman M
Exp Mol Pathol; 1982 Jun; 36(3):287-96. PubMed ID: 7084430
[No Abstract] [Full Text] [Related]
17. Histological study of homografts showing delayed rejection following levan administration.
Leibovici J; Wolman M; Bleiberg I
J Pathol; 1978 Jun; 125(2):103-6. PubMed ID: 363991
[TBL] [Abstract][Full Text] [Related]
18. Histological changes in spleen and lymph nodes of mice administered cyclophosphamide and levan.
Siegal A; Kopel S; Leibovici J
Cell Tissue Res; 1986; 245(1):183-8. PubMed ID: 3488127
[TBL] [Abstract][Full Text] [Related]
19. Effect of high molecular levan on implantation and embryonic development in mice.
Fein A; Berman Z; Wolman M
Isr J Med Sci; 1981 Dec; 17(12):1127-31. PubMed ID: 7327912
[TBL] [Abstract][Full Text] [Related]
20. Increase in cell permeability to a cytotoxic agent by the polysaccharide levan.
Leibovici J; Stark Y
Cell Mol Biol; 1985; 31(5):337-41. PubMed ID: 4084938
[No Abstract] [Full Text] [Related]
[Next] [New Search]